Buy REGENXBIO Stock | RGNX Stock Price & Latest News | Public.com
RGNX

REGENXBIO

$0.00 (0.00%)Today
    View REGENXBIO (RGNX) stock trends here

    About RGNX

    REGENXBIO, Inc. is a biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. The company was founded by Kennth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Roc...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0.23
    -0.26
    -0.74
    -1.23
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$1.23

    Actual EPS
    Q1 2021

    Stats

    Market Cap$1,7B
    Volume457,78k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$50.26
    1 Year Low$20.03
    Open$40.10
    High$41.27
    Low$38.97

    Buy any stock with any amount of money.

    Download the App
    Download the app